Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema

International Journal of Medical Sciences

Volumn 5, Issue 1, 2008, Pages 18-23

  Modrego, Pedro J ^a   Boned, Beatriz ^b   Berlanga, Juan J ^b   Serrano, Mercedes ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b Hospital de Alcañiz   (Spain)

Author keywords

B type natriuretic peptide; Brain edema; C reactive protein; Stroke

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLEEDING DISORDER; BRAIN EDEMA; BRAIN SCINTISCANNING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DEATH; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; OBESITY; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 38349180462     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.5.18     Document Type: Article

References (31)

1. th ed. McGraw-Hill: New York. 1998: 210-214.
2. Strunk A, Bhalla V, Clopton P, et al. Impact of the history of congestive heart failure on the utlity of B-Type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study. Am J Med. 2006; 119: 69e1-69e11.
3. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-Type Natriuretic Peptide and long-term mortality in stable coronary heart disease. N Engl J Med. 2005; 352: 666-675.
4. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005; 293: 1609-1616.
5. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 2002; 105: 2392-2397.
6. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med. 2004; 350: 655-663.
7. Campbell DJ, Woodward M, Chalmers JP, et al. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension. 2005; 45: 69-74.
8. Campbell DJ, Woodward M, Chalmers JP, et al. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease. Circulation. 2005; 112: 110-116.
9. Campbell DJ, Woodward M, Chalmers JP, et al. Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. Arch Neurol. 2006; 63: 60-65.
10. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke. 2001; 32: 2575-2579.
11. Estrada V, Tellez MJ, Moya J, Fernandez-Durango R, Egido J, Fernández-Cruz AF. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens. 1994; 7: 1085-1089.
12. Sato Y, Maruoka H, Honda Y, Hachiya N, Oizumi K. Plasma concentration of atrial natriuretic peptide in cardioembolic stroke with atrial fibrillation. Kurume Med J. 1995; 42: 71-77.
13. Makikallio AM, Makikallio TH, Korpelainen JT, et al. Natriuretic peptides and mortality after stroke. Stroke 2005; 36: 1016-1020.
14. Etgen T, Baum H, Sander K, Sander D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke. 2005; 36: 270-275.
15. Giannakoulas G, Hatzitolios A, Karvounis H, et al. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology. 2005; 56: 723-730.
16. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke. 2006; 37: 2018-2023.
17. Audeberg HJ, Rott MM, Eck T, Haberl RL. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 2004; 35: 2128-2133.
18. Marquardt L, Ruf A, Mansmann U, Winter R, Buggle F, Kallenberg K, Grau AJ. Inflammatory response after acute ischemic stroke. J Neurol Sci. 2005; 236: 65-71.
19. Masotti L, Ceccarelli E, Forconi S, Cappelli R. Prognostic role of C-reactive protein in very old patients with acute ischemic stroke. J Intern Med. 2005; 258: 145-152.
20. Rallidis LS, Vikelis M, Panagiotakos DB, et al. Inflammatory markers and in-hospital mortality in acute ischemic stroke. Atherosclerosis. 2005.
21. Kocer A, Canbulat C, Gozke E, Ilhan A. C-reactive protein is an indicator for fatal outcomes in first-time stroke patients. Med Sci Monit. 2005; 11: CR540-544.
22. Arevalo-Lorido JC, Carretero-Gomez J, Calvo-Romero JM, et al. C-reactive protein in the acute phase of ischemic stroke. Med Clin (Barc). 2005; 125: 775-777.
23. Paffen E, DeMaat MP. C-reactive protein in atherosclerosis: A causal factor? Cardiovasc Res. 2006; 71: 30-39.
24. Yip HK, Sun CK, Chang LT, Chen MC, Liou CW. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke. Circ J. 2006; 70: 447-452.
25. Jensen JK, Mickley H, Bak S, Korsholm L, Kristensen SR. Serial measurements of N-terminal pro-brain natriuretic peptide alter acute ischemic stroke. Cerebrovasc Dis 2006; 22:439-444
26. Tomida M, Muraki M, Uemura K, Yamasaki K. Olasma concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage. Stroke. 1998; 29: 1584-1587.
27. McGirt MJ, Blessing R, Nimjee SM, et al. Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage. Neurosurgery. 2004; 54: 1369-1373.
28. Fukui S, Nawashiro H, Otani N, et al. Focal brain edema and natriuretic peptides in patients with subarachnoid hemorrhage. Acta Neurochir (Wien). 2003; 86: 489-491.
29. Doczi TP, Joo F, Balas I. Atrial natriuretic peptide (ANP) attenuates brain edema accompanying experimental subarachnoid hemorrhage. Acta Neurochir (Wien). 1995; 132: 87-91.
30. Rosenberg GA, Estrada EY. Atrial natriuretic peptide blocks hemorrhagic brain edema after 4-hour delay in rats. Stroke. 1995; 26: 874-877.
31. Nogami M, Shiga J, Takatsu A, Endo N, Ishiyama I. Immunohistochemistry of atrial natriuretic peptide in brain infarction. Histochem J. 2001; 33: 87-90.